According to a new report Asia Pacific Life Science Analytics Market, published by KBV research, the Asia Pacific Life Science Analytics Market would witness market growth of 10.2% CAGR during the forecast period (2020-2026).
The China market dominated the Asia Pacific Biotechnology Market by Country 2019, and would continue to be a dominant market till 2026. The Japan market is experiencing a CAGR of 11.2% during (2020 - 2026). Additionally, The India market is poised to witness a CAGR of 12.4% during (2020 - 2026).
The On-Premise market dominated the South Korea Life Science Analytics Market by Delivery Mode 2019, growing at a CAGR of 11.6 % during the forecast period. The On-demand market is expected to witness a CAGR of 13.3% during (2020 - 2026).
The Descriptive market dominated the Malaysia Life Science Analytics Market by Type 2019, thereby, achieving a market value of $57.2 million by 2026. The Predictive market is estimated to grow at a CAGR of 11.7% during (2020 - 2026). The Reporting market would showcase a CAGR of 14.5% during (2020 - 2026). Additionally, The Prescriptive market is exhibiting a CAGR of 13.8% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/asia-pacific-life-science-analytics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Oracle Corporation, IBM Corporation, Microsoft Corporation, Accenture PLC, Cognizant Technology Solutions Corporation, Infosys Limited, IQVIA Holdings, Inc., AllScripts Healthcare Solutions, Inc., Cerner Corporation and SAS Institute, Inc.
By Component
By Application
By End User
By Delivery Mode
By Type
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
